Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
Main Authors: | Jose W. Ricardo, MD, Shari R. Lipner, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-11-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512621006433 |
Similar Items
-
Yellow nail syndrome
by: A. V. Motorina, et al.
Published: (2021-12-01) -
Deformed nail from stress related to childbearing
by: Ryuichi Ohta
Published: (2020-01-01) -
Rapidly and successful improvement of nail psoriasis with risankizumab
by: Diego Orsini, et al.
Published: (2023-10-01) -
Pattern diagnosis of onycholysis
by: Lourdes Navarro
Published: (2023-06-01) -
Optimal diagnosis and management of common nail disorders
by: Debra K. Lee, et al.
Published: (2022-12-01)